1 Study Coverage 1.1 Gastric Cancer Testing, Treatment and Prevention Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Introduction 1.2 Global Gastric Cancer Testing, Treatment and Prevention Outlook 2017 VS 2022 VS 2028 1.2.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size for the Year 2017-2028 1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size for the Year 2017-2028 1.3 Gastric Cancer Testing, Treatment and Prevention Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Gastric Cancer Testing, Treatment and Prevention in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Gastric Cancer Testing, Treatment and Prevention Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Gastric Cancer Testing, Treatment and Prevention Market Dynamics 1.4.1 Gastric Cancer Testing, Treatment and Prevention Industry Trends 1.4.2 Gastric Cancer Testing, Treatment and Prevention Market Drivers 1.4.3 Gastric Cancer Testing, Treatment and Prevention Market Challenges 1.4.4 Gastric Cancer Testing, Treatment and Prevention Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Gastric Cancer Testing, Treatment and Prevention by Type 2.1 Gastric Cancer Testing, Treatment and Prevention Market Segment by Type 2.1.1 Test 2.1.2 Treatment 2.1.3 Prevention 2.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017, 2022 & 2028) 2.3 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017-2028) 2.4 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017, 2022 & 2028) 2.5 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017-2028) 3 Gastric Cancer Testing, Treatment and Prevention by Application 3.1 Gastric Cancer Testing, Treatment and Prevention Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.1.3 Other 3.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017, 2022 & 2028) 3.3 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017-2028) 3.4 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017, 2022 & 2028) 3.5 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017-2028) 4 Global Gastric Cancer Testing, Treatment and Prevention Competitor Landscape by Company 4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Company 4.1.1 Top Global Gastric Cancer Testing, Treatment and Prevention Companies Ranked by Revenue (2021) 4.1.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue by Player (2017-2022) 4.2 Global Gastric Cancer Testing, Treatment and Prevention Concentration Ratio (CR) 4.2.1 Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Gastric Cancer Testing, Treatment and Prevention in 2021 4.2.3 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Gastric Cancer Testing, Treatment and Prevention Headquarters, Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Type 4.3.1 Global Gastric Cancer Testing, Treatment and Prevention Headquarters and Area Served 4.3.2 Global Gastric Cancer Testing, Treatment and Prevention Companies Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Gastric Cancer Testing, Treatment and Prevention Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Company 4.5.1 Top Gastric Cancer Testing, Treatment and Prevention Players in United States, Ranked by Revenue (2021) 4.5.2 United States Gastric Cancer Testing, Treatment and Prevention Revenue by Players (2020, 2021 & 2022) 5 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region 5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2017-2028) 5.2.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region: 2017-2022 5.2.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2017-2028 6.1.2 North America Gastric Cancer Testing, Treatment and Prevention Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2017-2028 6.3.2 Europe Gastric Cancer Testing, Treatment and Prevention Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2017-2028 6.4.2 Latin America Gastric Cancer Testing, Treatment and Prevention Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Biogen Idec 7.1.1 Biogen Idec Company Details 7.1.2 Biogen Idec Business Overview 7.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Introduction 7.1.4 Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.1.5 Biogen Idec Recent Development 7.2 Bristol Myers Squibb 7.2.1 Bristol Myers Squibb Company Details 7.2.2 Bristol Myers Squibb Business Overview 7.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Introduction 7.2.4 Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.2.5 Bristol Myers Squibb Recent Development 7.3 Eli Lilly And Company 7.3.1 Eli Lilly And Company Company Details 7.3.2 Eli Lilly And Company Business Overview 7.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Introduction 7.3.4 Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.3.5 Eli Lilly And Company Recent Development 7.4 Glaxosmithkline Genentech, Inc 7.4.1 Glaxosmithkline Genentech, Inc Company Details 7.4.2 Glaxosmithkline Genentech, Inc Business Overview 7.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Introduction 7.4.4 Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.4.5 Glaxosmithkline Genentech, Inc Recent Development 7.5 Hoffmann-La Roche Inc. 7.5.1 Hoffmann-La Roche Inc. Company Details 7.5.2 Hoffmann-La Roche Inc. Business Overview 7.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Introduction 7.5.4 Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.5.5 Hoffmann-La Roche Inc. Recent Development 7.6 Immunogen Merck & Company 7.6.1 Immunogen Merck & Company Company Details 7.6.2 Immunogen Merck & Company Business Overview 7.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Introduction 7.6.4 Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.6.5 Immunogen Merck & Company Recent Development 7.7 Novartis 7.7.1 Novartis Company Details 7.7.2 Novartis Business Overview 7.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Introduction 7.7.4 Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.7.5 Novartis Recent Development 7.8 Pacific Edge Diagnostics Nz 7.8.1 Pacific Edge Diagnostics Nz Company Details 7.8.2 Pacific Edge Diagnostics Nz Business Overview 7.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Introduction 7.8.4 Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.8.5 Pacific Edge Diagnostics Nz Recent Development 7.9 Pfizer 7.9.1 Pfizer Company Details 7.9.2 Pfizer Business Overview 7.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Introduction 7.9.4 Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.9.5 Pfizer Recent Development 7.10 Roche/Genentech Oncolytics 7.10.1 Roche/Genentech Oncolytics Company Details 7.10.2 Roche/Genentech Oncolytics Business Overview 7.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Introduction 7.10.4 Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.10.5 Roche/Genentech Oncolytics Recent Development 7.11 Zova Biotherapeutics Inc. 7.11.1 Zova Biotherapeutics Inc. Company Details 7.11.2 Zova Biotherapeutics Inc. Business Overview 7.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Introduction 7.11.4 Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) 7.11.5 Zova Biotherapeutics Inc. Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Gastric Cancer Testing, Treatment and Prevention Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Gastric Cancer Testing, Treatment and Prevention Market Trends Table 3. Gastric Cancer Testing, Treatment and Prevention Market Drivers Table 4. Gastric Cancer Testing, Treatment and Prevention Market Challenges Table 5. Gastric Cancer Testing, Treatment and Prevention Market Restraints Table 6. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Gastric Cancer Testing, Treatment and Prevention Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Gastric Cancer Testing, Treatment and Prevention Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Gastric Cancer Testing, Treatment and Prevention Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Player, 2017-2022 Table 13. Global Gastric Cancer Testing, Treatment and Prevention Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Gastric Cancer Testing, Treatment and Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Testing, Treatment and Prevention as of 2021) Table 15. Top Players of Gastric Cancer Testing, Treatment and Prevention in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Gastric Cancer Testing, Treatment and Prevention Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Gastric Cancer Testing, Treatment and Prevention Players in United States Market, Ranking by Revenue (2021) Table 20. United States Gastric Cancer Testing, Treatment and Prevention Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Gastric Cancer Testing, Treatment and Prevention Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Gastric Cancer Testing, Treatment and Prevention Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Gastric Cancer Testing, Treatment and Prevention Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Gastric Cancer Testing, Treatment and Prevention Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Gastric Cancer Testing, Treatment and Prevention Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Biogen Idec Company Details Table 31. Biogen Idec Business Overview Table 32. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product Table 33. Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 34. Biogen Idec Recent Development Table 35. Bristol Myers Squibb Company Details Table 36. Bristol Myers Squibb Business Overview Table 37. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product Table 38. Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 39. Bristol Myers Squibb Recent Development Table 40. Eli Lilly And Company Company Details Table 41. Eli Lilly And Company Business Overview Table 42. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product Table 43. Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 44. Eli Lilly And Company Recent Development Table 45. Glaxosmithkline Genentech, Inc Company Details Table 46. Glaxosmithkline Genentech, Inc Business Overview Table 47. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product Table 48. Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 49. Glaxosmithkline Genentech, Inc Recent Development Table 50. Hoffmann-La Roche Inc. Company Details Table 51. Hoffmann-La Roche Inc. Business Overview Table 52. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product Table 53. Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 54. Hoffmann-La Roche Inc. Recent Development Table 55. Immunogen Merck & Company Company Details Table 56. Immunogen Merck & Company Business Overview Table 57. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product Table 58. Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 59. Immunogen Merck & Company Recent Development Table 60. Novartis Company Details Table 61. Novartis Business Overview Table 62. Novartis Gastric Cancer Testing, Treatment and Prevention Product Table 63. Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 64. Novartis Recent Development Table 65. Pacific Edge Diagnostics Nz Company Details Table 66. Pacific Edge Diagnostics Nz Business Overview Table 67. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product Table 68. Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 69. Pacific Edge Diagnostics Nz Recent Development Table 70. Pfizer Company Details Table 71. Pfizer Business Overview Table 72. Pfizer Gastric Cancer Testing, Treatment and Prevention Product Table 73. Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 74. Pfizer Recent Development Table 75. Roche/Genentech Oncolytics Company Details Table 76. Roche/Genentech Oncolytics Business Overview Table 77. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product Table 78. Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 79. Roche/Genentech Oncolytics Recent Development Table 80. Zova Biotherapeutics Inc. Company Details Table 81. Zova Biotherapeutics Inc. Business Overview Table 82. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product Table 83. Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) & (US$ Million) Table 84. Zova Biotherapeutics Inc. Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Gastric Cancer Testing, Treatment and Prevention Product Picture Figure 2. Global Gastric Cancer Testing, Treatment and Prevention Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Gastric Cancer Testing, Treatment and Prevention Market Size 2017-2028 (US$ Million) Figure 4. United States Gastric Cancer Testing, Treatment and Prevention Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Gastric Cancer Testing, Treatment and Prevention Market Size 2017-2028 (US$ Million) Figure 6. United States Gastric Cancer Testing, Treatment and Prevention Market Share in Global 2017-2028 Figure 7. Gastric Cancer Testing, Treatment and Prevention Report Years Considered Figure 8. Product Picture of Test Figure 9. Product Picture of Treatment Figure 10. Product Picture of Prevention Figure 11. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Type in 2022 & 2028 Figure 12. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2017-2028) Figure 14. United States Gastric Cancer Testing, Treatment and Prevention Market Share by Type in 2022 & 2028 Figure 15. United States Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2017-2028) Figure 17. Product Picture of Hospitals Figure 18. Product Picture of Clinics Figure 19. Product Picture of Other Figure 20. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application in 2022 & 2028 Figure 21. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2017-2028) Figure 23. United States Gastric Cancer Testing, Treatment and Prevention Market Share by Application in 2022 & 2028 Figure 24. United States Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2017-2028) Figure 26. North America Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. UAE Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Biogen Idec Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 55. Bristol Myers Squibb Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 56. Eli Lilly And Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 57. Glaxosmithkline Genentech, Inc Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 58. Hoffmann-La Roche Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 59. Immunogen Merck & Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 60. Novartis Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 61. Pacific Edge Diagnostics Nz Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 62. Pfizer Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 63. Roche/Genentech Oncolytics Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 64. Zova Biotherapeutics Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Biogen Idec Bristol Myers Squibb Eli Lilly And Company Glaxosmithkline Genentech, Inc Hoffmann-La Roche Inc. Immunogen Merck & Company Novartis Pacific Edge Diagnostics Nz Pfizer Roche/Genentech Oncolytics Zova Biotherapeutics Inc.